Cancel
Anagenex
See Linkedin
Anagenex Employees
28 people indexed:
-
kflwp2@lzqffus0.fjj Sign up to see email
-
sv0q6i@tk65y8ys.8uy Sign up to see email
-
dfvs7@2f2vs3s0.u5d Sign up to see email
-
rfjrp@095d0z2r.825 Sign up to see email
-
8k2@vdr58093.2ud Sign up to see email
-
zll1@fi7w31kz.hqh Sign up to see email
-
3w7ur1@y0d7z103.l6l Sign up to see email
-
Kaileigh Cloutier-LeBlanc
Senior Research Associate, Biology
f5bf6q1w@v9jvuz7p.7tp Sign up to see email149q5uq3@59qdqj38.j56 Sign up to see email -
9ppjs@7rqs63di.sb1 Sign up to see email
-
f6d@295dyljw.8fl Sign up to see email
-
bv3wufktz@0vk41wzj.jtj Sign up to see email
-
2t64@524jkb3f.sq0 Sign up to see email
-
7wp390s@42ys4f17.dyu Sign up to see email
-
3ifw@24iifzzw.uz5 Sign up to see email
-
p9l13r@wstb9w40.i9q Sign up to see email
-
1j7uf@2f4qs0b8.022 Sign up to see email
-
tz1j@fst5f8jw.30b Sign up to see email
-
7p1tw0h@z1kq5df1.fw2 Sign up to see email
-
Olga Yuzhakov
Principal Scientist, Cell Biology and Assay Development
sw20@j0p6u08d.6f7 Sign up to see emailqvbd@3349qhhy.r24 Sign up to see email -
f69us4@yf4vwjrw.kb5 Sign up to see email
-
jlb748t2@fl2sqt3b.s59 Sign up to see email
-
v1qhsi@yyj8hz36.71y Sign up to see email
-
7l1q@6k8u2spu.97w Sign up to see email
-
ivy3@zrt0fujj.22z Sign up to see email
-
5178i9@d30hw33w.jv0 Sign up to see email
-
fp2t46@ywliz974.v8f Sign up to see email
-
0h1z@0rbw24df.hpp Sign up to see email
-
ky6p@kyqybu82.bsp Sign up to see email
Anagenex Company Information
Anagenex, based in Lexington, MA, is a pioneering biotechnology firm dedicated to the discovery of small molecule therapeutics. The company recently expanded its leadership by appointing Adrian Schreyer, Ph.D., as Chief Technology Officer and Ryan Kruger as Chief Scientific Officer, both of whom are veterans in pharmaceutical research and development. Anagenex has also strengthened its Board of Directors with the additions of Robert Forrester and Isaac Ro. Furthermore, the company has announced a multi-target collaboration aimed at developing therapeutics for multiple indications. Recently, Anagenex secured a significant financial milestone by closing a $30 million Series A funding round, led by Catalio, to further enhance their innovative drug discovery platform. The company is located at 20 Maguire Rd Suite 302, Lexington, MA 02421, and can be contacted at (978) 444-2649.
Report inaccurate information
Report inaccurate information
